Legal & General Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.44M | Buy |
278,274
+24,582
| +10% | +$186K | ﹤0.01% | 1894 |
|
|
2026
Q1 | $1.95M | Sell |
253,692
-38,776
| -13% | -$265K | ﹤0.01% | 1921 |
|
|
2025
Q4 | $579K | Buy |
292,468
+69,580
| +31% | +$158K | ﹤0.01% | 2380 |
|
|
2025
Q3 | $548K | Buy |
222,888
+17,410
| +8% | +$44.8K | ﹤0.01% | 2428 |
|
|
2025
Q2 | $542K | Buy |
205,478
+21,715
| +12% | +$58.4K | ﹤0.01% | 2424 |
|
|
2025
Q1 | $553K | Buy |
183,763
+52,399
| +40% | +$159K | ﹤0.01% | 2370 |
|
|
2024
Q4 | $336K | Hold |
131,364
| – | – | ﹤0.01% | 2586 |
|
|
2024
Q3 | $488K | Buy |
131,364
+464
| +0.4% | +$2.15K | ﹤0.01% | 2470 |
|
|
2024
Q2 | $827K | Buy |
130,900
+15,754
| +14% | +$104K | ﹤0.01% | 2256 |
|
|
2024
Q1 | $618K | Sell |
115,146
-5,383
| -4% | -$24.4K | ﹤0.01% | 2348 |
|
|
2023
Q4 | $605K | Buy |
120,529
+2,566
| +2% | +$8.05K | ﹤0.01% | 2379 |
|
|
2023
Q3 | $199K | Sell |
117,963
-1,403
| -1% | -$2.82K | ﹤0.01% | 2721 |
|
|
2023
Q2 | $332K | Buy |
119,366
+63,839
| +115% | +$181K | ﹤0.01% | 2591 |
|
|
2023
Q1 | $101K | Buy |
55,527
+10,679
| +24% | +$33.2K | ﹤0.01% | 2773 |
|
|
2022
Q4 | $227K | Sell |
44,848
-1,125
| -2% | -$6.18K | ﹤0.01% | 2557 |
|
|
2022
Q3 | $229K | Buy |
45,973
+3,936
| +9% | +$17.9K | ﹤0.01% | 2573 |
|
|
2022
Q2 | $157K | Buy |
42,037
+9,898
| +31% | +$39.8K | ﹤0.01% | 2719 |
|
|
2022
Q1 | $180K | Buy |
32,139
+1,163
| +4% | +$7.13K | ﹤0.01% | 2707 |
|
|
2021
Q4 | $188K | Hold |
30,976
| – | – | ﹤0.01% | 2744 |
|
|
2021
Q3 | $301K | Buy |
30,976
+18,555
| +149% | +$204K | ﹤0.01% | 2568 |
|
|
2021
Q2 | $178K | Buy |
12,421
+2,998
| +32% | +$49.5K | ﹤0.01% | 2567 |
|
|
2021
Q1 | $224K | Sell |
9,423
-8,167
| -46% | -$212K | ﹤0.01% | 2437 |
|
|
2020
Q4 | $234K | Buy |
17,590
+13,832
| +368% | +$133K | ﹤0.01% | 2386 |
|
|
2020
Q3 | $26K | Sell |
3,758
-829
| -18% | -$8.27K | ﹤0.01% | 2896 |
|
|
2020
Q2 | $56K | Buy |
+4,587
| New | +$25.9K | ﹤0.01% | 2696 |
|
|
2019
Q3 | – | Sell |
-4,489
| Closed | -$5K | – | 3385 |
|
|
2019
Q2 | $5K | Hold |
4,489
| – | – | ﹤0.01% | 3444 |
|
|
2019
Q1 | $7K | Hold |
4,489
| – | – | ﹤0.01% | 3287 |
|
|
2018
Q4 | $5K | Hold |
4,489
| – | – | ﹤0.01% | 3335 |
|
|
2018
Q3 | $17K | Hold |
4,489
| – | – | ﹤0.01% | 3247 |
|
|
2018
Q2 | $14K | Hold |
4,489
| – | – | ﹤0.01% | 3263 |
|
|
2018
Q1 | $17K | Sell |
4,489
-447
| -9% | -$1.96K | ﹤0.01% | 3137 |
|
|
2017
Q4 | $22K | Hold |
4,936
| – | – | ﹤0.01% | 3130 |
|
|
2017
Q3 | $27K | Hold |
4,936
| – | – | ﹤0.01% | 3090 |
|
|
2017
Q2 | $37K | Buy |
4,936
+2,313
| +88% | +$9.99K | ﹤0.01% | 2987 |
|
|
2017
Q1 | $9K | Sell |
2,623
-601
| -19% | -$2.97K | ﹤0.01% | 3203 |
|
|
2016
Q4 | $18K | Buy |
+3,224
| New | +$21.5K | ﹤0.01% | 3132 |
|
Other funds holding IBRX
Legal & General Group's IBRX Position: Q2 2026 in Review
Legal & General Group increased its ImmunityBio (IBRX) stake by 9.7% in Q2 2026, buying an estimated $186K and bringing the position to 278,274 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1894.
Legal & General Group first reported a position in IBRX in Q4 2016 and has held it in 36 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.
- Legal & General Group held 278,274 shares of ImmunityBio worth $2.44M as of Q2 2026.
- Legal & General Group bought 24,582 ImmunityBio shares in Q2 2026, an estimated $186K.
- ImmunityBio made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1894 holding.
- Legal & General Group first reported a position in ImmunityBio in Q4 2016 and has held it in 36 quarters since.
- 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.